Caseware UK (AP4) 2023.0.135 2023.0.135 2025-01-312025-01-312025-05-07falsefalse2024-02-01No description of principal activity00truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 09951386 2024-02-01 2025-01-31 09951386 2023-02-01 2024-01-31 09951386 2025-01-31 09951386 2024-01-31 09951386 c:Director2 2024-02-01 2025-01-31 09951386 d:FurnitureFittings 2024-02-01 2025-01-31 09951386 d:FurnitureFittings 2025-01-31 09951386 d:FurnitureFittings 2024-01-31 09951386 d:FurnitureFittings d:OwnedOrFreeholdAssets 2024-02-01 2025-01-31 09951386 d:CurrentFinancialInstruments 2025-01-31 09951386 d:CurrentFinancialInstruments 2024-01-31 09951386 d:CurrentFinancialInstruments d:WithinOneYear 2025-01-31 09951386 d:CurrentFinancialInstruments d:WithinOneYear 2024-01-31 09951386 d:ShareCapital 2025-01-31 09951386 d:ShareCapital 2024-01-31 09951386 d:FinancialAssetsDesignatedFairValueThroughProfitOrLoss 2025-01-31 09951386 d:FinancialAssetsDesignatedFairValueThroughProfitOrLoss 2024-01-31 09951386 c:FRS102 2024-02-01 2025-01-31 09951386 c:AuditExempt-NoAccountantsReport 2024-02-01 2025-01-31 09951386 c:FullAccounts 2024-02-01 2025-01-31 09951386 c:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 09951386 2 2024-02-01 2025-01-31 09951386 e:PoundSterling 2024-02-01 2025-01-31 iso4217:GBP xbrli:pure

Registered number: 09951386









OPHTHALMICORP LIMITED







UNAUDITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JANUARY 2025

 
OPHTHALMICORP LIMITED
REGISTERED NUMBER: 09951386

BALANCE SHEET
AS AT 31 JANUARY 2025

2025
2024
Note
£
£

Fixed assets
  

Tangible assets
 4 
346
462

  
346
462

Current assets
  

Debtors: amounts falling due within one year
 5 
1,633
2,157

Cash at bank and in hand
 6 
21,048
15,532

  
22,681
17,689

Creditors: amounts falling due within one year
 7 
(23,025)
(18,149)

Net current liabilities
  
 
 
(344)
 
 
(460)

Total assets less current liabilities
  
2
2

  

Net assets
  
2
2


Capital and reserves
  

Called up share capital 
  
2
2

  
2
2


Page 1

 
OPHTHALMICORP LIMITED
REGISTERED NUMBER: 09951386
    
BALANCE SHEET (CONTINUED)
AS AT 31 JANUARY 2025

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 7 May 2025.




................................................
Joshua Owen Thomas
Director

The notes on pages 3 to 7 form part of these financial statements.

Page 2

 
OPHTHALMICORP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2025

1.


General information

The Company is a private company limited by shares, incorporated in England. The principal activity throughout the year was the provision of administrative, managerial, marketing and financial services.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Revenue

Turnover is recognised to the extent that it is probable that the economic benefits will flow to the Company and the turnover can be reliably measured. Turnover is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before turnover is recognised:

Rendering of services

Turnover from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of turnover can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.4

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.


Page 3

 
OPHTHALMICORP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2025

2.Accounting policies (continued)

 
2.5

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on a reducing balance basis.

Depreciation is provided on the following basis:

Fixtures and fittings
-
25% reducing balance

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.6

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.7

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.8

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.9

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The Company has no employees other than the directors, who did not receive any remuneration (2024 - £Nil).

Page 4

 
OPHTHALMICORP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2025

4.


Tangible fixed assets





Fixtures and fittings

£



Cost or valuation


At 1 February 2024
3,460



At 31 January 2025

3,460



Depreciation


At 1 February 2024
2,998


Charge for the year on owned assets
116



At 31 January 2025

3,114



Net book value



At 31 January 2025
346



At 31 January 2024
462

Page 5

 
OPHTHALMICORP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2025

5.


Debtors

2025
2024
£
£


Trade debtors
1,500
-

Amounts owed by joint ventures and associated undertakings
-
1,964

Other debtors
2
2

Prepayments and accrued income
131
191

1,633
2,157



6.


Cash and cash equivalents

2025
2024
£
£

Cash at bank and in hand
21,048
15,532

21,048
15,532



7.


Creditors: Amounts falling due within one year

2025
2024
£
£

Amounts owed by joint ventures and associated undertakings
3,186
-

Corporation tax
18,339
16,649

Accruals and deferred income
1,500
1,500

23,025
18,149


Page 6

 
OPHTHALMICORP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2025

8.


Financial instruments

2025
2024
£
£

Financial assets


Financial assets measured at fair value through profit or loss
21,048
15,532




Financial assets measured at fair value through profit or loss comprise cash at bank and in hand.


9.


Controlling party

There is no overall controlling party.

 
Page 7